| 发明名称 |
NEW CLINICAL TREATMENT |
| 摘要 |
The invention relates to the use of an effective dose of N-acetyl-L-cysteine , or a dimeric form thereof, for the manufacturing of a drug for reverting mammalian neoplasia cells of epithelial origin back to a normal differentiation whereby the abnormal proliferation of the neoplasia cells is reverted to a normal pathway.
|
| 申请公布号 |
CA2432570(A1) |
申请公布日期 |
2002.07.04 |
| 申请号 |
CA20012432570 |
申请日期 |
2001.12.27 |
| 申请人 |
NACTILUS AB |
发明人 |
CONCETTA ROMANO, MARIA;LUNDEBERG, THOMAS |
| 分类号 |
A61K31/198;A61P3/10;A61P9/10;A61P9/14;A61P13/12;A61P17/00;A61P17/06;A61P29/00;A61P35/00;A61P35/04;A61P43/00;(IPC1-7):A61K31/198;A61K38/05 |
主分类号 |
A61K31/198 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
